Accordingly, our data showed a significant increase in the numbers of dermal mast cells following oxazolone-induced AD, while tempol topical administration lessened the presence of degranulating mast cells, highlighting a considerable decrease in allergic immune response which was also evidenced by the diminished levels of IgE, IL-4 and IL-13. This evidence concerns the gene IGHE and Alzheimer disease.